WealthPLAN Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,789
| Closed | -$216K | – | 274 |
|
|
2025
Q3 | $216K | Buy |
+4,789
| New | +$224K | 0.03% | 241 |
|
|
2023
Q3 | – | Sell |
-2,556
| Closed | -$163K | – | 408 |
|
|
2023
Q2 | $163K | Buy |
2,556
+152
| +6% | +$10.2K | 0.02% | 325 |
|
|
2023
Q1 | $167K | Sell |
2,404
-7,838
| -77% | -$553K | 0.02% | 343 |
|
|
2022
Q4 | $740K | Buy |
+10,242
| New | +$772K | 0.05% | 206 |
|
|
2022
Q1 | $760K | Sell |
10,097
-900
| -8% | -$60.4K | 0.05% | 199 |
|
|
2021
Q4 | $714K | Buy |
10,997
+115
| +1% | +$6.75K | 0.05% | 216 |
|
|
2021
Q3 | $622K | Sell |
10,882
-191
| -2% | -$12.6K | 0.04% | 223 |
|
|
2021
Q2 | $740K | Buy |
11,073
+161
| +1% | +$10.5K | 0.05% | 189 |
|
|
2021
Q1 | $698K | Sell |
10,912
-1,673
| -13% | -$104K | 0.05% | 184 |
|
|
2020
Q4 | $775K | Sell |
12,585
-26
| -0.2% | -$1.6K | 0.07% | 160 |
|
|
2020
Q3 | $791K | Buy |
12,611
+310
| +3% | +$18.7K | 0.08% | 142 |
|
|
2020
Q2 | $778K | Sell |
12,301
-375
| -3% | -$22.4K | 0.08% | 132 |
|
|
2020
Q1 | $808K | Buy |
12,676
+1,267
| +11% | +$77.4K | 0.1% | 118 |
|
|
2019
Q4 | $765K | Buy |
11,409
+1,408
| +14% | +$80.6K | 0.09% | 128 |
|
|
2019
Q3 | $588K | Sell |
10,001
-73
| -0.7% | -$3.43K | 0.08% | 139 |
|
|
2019
Q2 | $469K | Sell |
10,074
-522
| -5% | -$24.3K | 0.07% | 152 |
|
|
2019
Q1 | $495K | Buy |
10,596
+1,604
| +18% | +$79.9K | 0.08% | 166 |
|
|
2018
Q4 | $465K | Sell |
8,992
-17,117
| -66% | -$920K | 0.07% | 161 |
|
|
2018
Q3 | $1.4M | Buy |
26,109
+1,901
| +8% | +$113K | 0.26% | 81 |
|
|
2018
Q2 | $1.34M | Buy |
24,208
+4,168
| +21% | +$225K | 0.27% | 87 |
|
|
2018
Q1 | $1.27M | Buy |
20,040
+14,161
| +241% | +$911K | 0.28% | 88 |
|
|
2017
Q4 | $360K | Sell |
5,879
-405
| -6% | -$25.3K | 0.1% | 148 |
|
|
2017
Q3 | $401K | Sell |
6,284
-7,926
| -56% | -$463K | 0.11% | 127 |
|
|
2017
Q2 | $792K | Buy |
14,210
+13,184
| +1,285% | +$717K | 0.23% | 81 |
|
|
2017
Q1 | $54.5K | Buy |
+1,026
| New | +$56.3K | 0.19% | 104 |
|
|
2016
Q3 | $817K | Sell |
14,791
-9,049
| -38% | -$581K | 0.27% | 61 |
|
|
2016
Q2 | $1.08M | Buy |
+23,840
| New | +$1.68M | 0.14% | 115 |
|
|
2015
Q4 | $995K | Buy |
+43,208
| New | +$2.86M | 0.16% | 101 |
|
|
2015
Q2 | $665K | Sell |
9,991
-991
| -9% | -$65.3K | 0.29% | 44 |
|
|
2015
Q1 | $708K | Buy |
+10,982
| New | +$688K | 0.33% | 56 |
|
Other funds holding BMY
WealthPLAN Partners's BMY Position: Q4 2025 in Review
WealthPLAN Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 4,789 shares — an estimated $216K sold.
WealthPLAN Partners first reported a position in BMY in Q1 2015 and held it in 30 quarters. The position peaked at $1.4M in Q3 2018. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- WealthPLAN Partners reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- WealthPLAN Partners sold 4,789 Bristol-Myers Squibb shares in Q4 2025, an estimated $216K.
- WealthPLAN Partners first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 30 quarters.
- WealthPLAN Partners's Bristol-Myers Squibb position peaked at $1.4M in Q3 2018.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on WealthPLAN Partners's 13F filing for Q4 2025, filed 12 Feb 2026.